The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Histomics as an emerging avenue for oncology biomarker development: Computational Histology Artificial Intelligence (CHAI) analysis of The Cancer Genome Atlas (TCGA).
 
Richard Goldberg
Employment - Agenus
Leadership - Agenus
Stock and Other Ownership Interests - Agenus; Compass Therapeutics; Quest Diagnostics
Consulting or Advisory Role - Agenus; Compass Therapeutics; Cytel; Haystack Oncology; Innovative Cellular Therapeutics Co; Inspirna; Merck; Modulation Therapeutics; Takeda; UpToDate; Valar Labs; WCG; WUGEN, Inc.
Expert Testimony - Johns Hopkins Hospital
Travel, Accommodations, Expenses - Mass General Brigham
(OPTIONAL) Uncompensated Relationships - Fight Colorectal Cancer
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Sumanta Pal
Speakers' Bureau - IntrinsiQ; MJH Life Sciences; Peerview
Research Funding - Adicet Bio (Inst); Adicet Bio (Inst); ArsenalBio (Inst); crispr therapeutics (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Miyarisan pharmaceutical (Inst); Osel (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen
 
Vrishab Krishna
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - Valar Labs patents
 
Viswesh Krishna
Employment - Valar Labs
Leadership - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - Valar Labs patents
 
Gaurav Kaul
Employment - Valar Labs
 
Akshay Neema
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Other Relationship - Valar Labs
 
Asit Tarsode
Employment - Picture Health; Valar Labs
Stock and Other Ownership Interests - Tempus; Valar Labs
 
Haochen Zhang
Employment - Valar Labs; Valar Labs
Stock and Other Ownership Interests - Lilly; Moderna Therapeutics; Revolution Medicines; Valar Labs
 
Ekin Tiu
No Relationships to Disclose
 
Lesli Kiedrowski
Employment - Guardant Health; Valar Labs
Stock and Other Ownership Interests - Guardant Health; Valar Labs
 
Trevor Royce
Employment - ArteraAI; Flatiron Health; Valar Labs
Stock and Other Ownership Interests - Deep Blue Medical; Galaxy Diagnostics; Lumata Health; mPATH; Roche; SonoVascular; VitriVax
Consulting or Advisory Role - Agilix Health
 
Anirudh Joshi
Employment - Intuitive Surgical (I); Valar Labs
Leadership - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - Valar Labs patents under review
Travel, Accommodations, Expenses - Valar Labs
 
Charu Aggarwal
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novocure; Pfizer
Speakers' Bureau - AstraZeneca (I)
Research Funding - AstraZeneca/MedImmune (Inst); Candel Therapeutics (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genmab; Loxo@Lilly (Inst); Merck Sharp & Dohme (Inst)
 
Sue Yom
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); J&J (Inst); Merck (Inst)
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Andrew Hendifar
Consulting or Advisory Role - Alcresta Therapeutics; Amgen; Curium Pharma; Exelixis; Faraday Pharmaceuticals; Ipsen; Merck; Novartis; Pancreatic Cancer Action Network; Pfizer; Regeneron; Valar Labs
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - Rayzebio
 
Eric Collisson
Stock and Other Ownership Interests - BloodQ; Clara Health; Guardant Health; HDT Bio; Hint Health; IHP Therapeutics; One Medical; Tatara Therapeutics; Valar Labs
 
Ashish Kamat
Leadership - American Urological Association; International Bladder Cancer Group (IBCG); World Bladder Cancer Patient Coalition
Consulting or Advisory Role - Aspira Women's Health (I); Astellas Pharma; Atonco Pharma; Biological Dynamics; Bristol-Myers Squibb; CG Oncology; Cystotech; Eisai; enGene; Ferring; Genentech; Imagin Medical; ImmunityBio; Imvax; Incyte; Janssen; Medac; Merck; Nonagen Bioscience; Pfizer; Photocure; Protara Therapeutics; Roche; Seagen; Sesen Bio; Theralase; Urogen pharma; US Biotest; Valar Labs; Vivet Therapeutics
Research Funding - Arquer Diagnostics (Inst); enGene (Inst); FKD Therapies (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Photocure (Inst); Seagen (Inst); SWOG (Inst)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - European Urology Oncology; Journal of Urology; UroToday
 
John Kirkwood
Consulting or Advisory Role - Ankyra Therapeutics; AXIO Research; Boxer Capital; Bristol Myers Squibb; Daiichi Sankyo; Engage Health Media; GE Healthcare; Intellisphere; IQVIA; Istari; Lumira Capital Investment Management; Lytix Biopharma; Merck; Mural Oncology; Natera; Novartis; OncoCyte; Pfizer; Piper Sandler; PyrOjas Corporation; Regeneron; Replimune; Scitaris GmbH & Co. KG; Sun Pharma; Syntaxx Communications; Takeda; Valar Labs; Zola Therapeutics
Research Funding - Ankyra Therapeutics (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); Harbour BioMed (Inst); Immunocore (Inst); Immvira (Inst); Iovance Biotherapeutics (Inst); Lion Biotechnologies (Inst); Lytix Biopharma (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst); Takeda (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lumanity; Regeneron